Drucken

MITTEILUNG UEBERMITTELT VON BUSINESS WIRE. FUER DEN INHALT IST ALLEIN DAS BERICHTENDE UNTERNEHMEN VERANTWORTLICH.

BOSTON --(BUSINESS WIRE)-- 10.10.2024 --

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its third quarter 2024 financial results on Monday, November 4, 2024 after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. To access the call, please dial (833) 630-2124 (U.S.) or +1 (412) 317-0651 (International) and reference the "Vertex Pharmaceuticals Third Quarter 2024 Earnings Call."

The conference call will be webcast live and a link to the webcast can be accessed through Vertex's website at www.vrtx.com in the "Investors" section. To ensure a timely connection, it is recommended that participants register at least 15 minutes prior to the scheduled webcast. An archived webcast will be available on the company's website.

About Vertex

Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has approved medicines that treat the underlying causes of multiple chronic, life-shortening genetic diseases - cystic fibrosis, sickle cell disease and transfusion-dependent beta thalassemia - and continues to advance clinical and research programs in these diseases. Vertex also has a robust clinical pipeline of investigational therapies across a range of modalities in other serious diseases where it has deep insight into causal human biology, including acute and neuropathic pain, APOL1-mediated kidney disease, IgA nephropathy, autosomal dominant polycystic kidney disease, type 1 diabetes and myotonic dystrophy type 1.

Vertex was founded in 1989 and has its global headquarters in Boston, with international headquarters in London. Additionally, the company has research and development sites and commercial offices in North America, Europe, Australia, Latin America and the Middle East. Vertex is consistently recognized as one of the industry's top places to work, including 14 consecutive years on Science magazine's Top Employers list and one of Fortune's 100 Best Companies to Work For. For company updates and to learn more about Vertex's history of innovation, visit www.vrtx.com or follow us on LinkedIn, Facebook, Instagram, YouTube and X.

(VRTX-WEB)

Vertex Pharmaceuticals Incorporated Investor Relations:
investorinfo@vrtx.com

Business Wire

Zeit Meldung
04:42 BUSINESS WIRE: Geekvape und Geekbar glänzen bei de
02.11. BUSINESS WIRE: CRH entwickelt Windpark zur Stromve
02.11. BUSINESS WIRE: NielsenIQ (NIQ) ernennt Steen Lomho
02.11. BUSINESS WIRE: Rampur Distillery feiert Diwali am
01.11. BUSINESS WIRE: MyGuava und Crystal Palace führen a
01.11. BUSINESS WIRE: teamLab Planets TOKYO wird erheblic
01.11. BUSINESS WIRE: Medidata führt gebündelte Lösungen
01.11. BUSINESS WIRE: Adtran and Sonic Fiber Internet par
01.11. BUSINESS WIRE: Hassana Investment Company und EIG
01.11. BUSINESS WIRE: Rimini Street gibt Finanz- und Betr
01.11. BUSINESS WIRE: SCIVAX und Shin-Etsu Chemical haben
01.11. BUSINESS WIRE: Burger King® Japan kündigt die Japa
01.11. BUSINESS WIRE: Neutrogena® startet bahnbrechende Z
01.11. BUSINESS WIRE: Takeda gibt starke Ergebnisse für d
01.11. BUSINESS WIRE: ELIQUENT Life Sciences gibt bekannt
01.11. BUSINESS WIRE: Xsolla und Long Tale Games starten
31.10. BUSINESS WIRE: Kinaxis kündigt Aktienrückkauf über
31.10. BUSINESS WIRE: NetApp ernennt Pamela Hennard zum C
31.10. BUSINESS WIRE: Tigo Energy-Kunde wird Brasiliens g
31.10. BUSINESS WIRE: Medidata und Cogstate kooperieren b
31.10. BUSINESS WIRE: Xsolla führt Xsolla ZK ein und trei
31.10. BUSINESS WIRE: HTEC ernennt neuen globalen Vice Pr
31.10. BUSINESS WIRE: euNetworks stellt seinen nächsten S
31.10. BUSINESS WIRE: Arrow Electronics beschleunigt die
31.10. BUSINESS WIRE: LambdaTest führt neue Funktionen im

Mehr Marktdaten und Kurse finden Sie auf www.finanztreff.de

Angebote der
Nutzungshinweise | Datenschutz | Impressum | Datenquellen: boerse-stuttgart.de,